Applied Genetic Technologies (NASDAQ: AGTC) reported Q4 EPS of ($0.58), $0.04 worse than the analyst estimate of ($0.54). Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE